Berger, R., Rotem-Yehudar, R., Slama, G., Landes, S, Kneller, A., Leiba, M., Koren-Michowitz, M., Shimoni, A. and Nagler, A. (2008) Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malign-nancies. Clinical Cancer Research, 14, 3044-3051.doi10.1158/1078-0432.CCR-07-4079 - References

Journals by Subject

Publish with us

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Article citationsMore>>

Berger, R., Rotem-Yehudar, R., Slama, G., Landes, S, Kneller, A., Leiba, M., Koren-Michowitz, M., Shimoni, A. and Nagler, A. (2008) Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malign-nancies. Clinical Cancer Research, 14, 3044-3051. doi:10.1158/1078-0432.CCR-07-4079

has been cited by the following article:

TITLE: New era in cancer immunotherapy: Twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors

AUTHORS: Britta Hardy, Annat Raiter

KEYWORDS: Cancer Immunotherapy; Monoclonal Antibodies; Anergy; T Cell Receptors

JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.4 No.4A, April 29, 2013

ABSTRACT: The better understanding of the mechanism in which the immune system responds to the developing cancer provided the outcome in a new era in cancer immunotherapy. The tumor suppressive effect on the immune system is caused by negative T cell receptor signaling that abrogate immunity against the cancer cells. Novel monoclonal antibodies that target co-inhibitory receptors on T cells block the tumor induced inhibition of the immune system and enable the immune system to eradicate the tumors. The development of such antibodies started twenty years ago by the preparation of a monoclonal antibody termed BAT. A single administration of the antibody to tumor bearing mice resulted in striking anti tumor activity that was mediated by the lymphocytes. These studies provided a basis for the new era of cancer immunotherapy. The present review summarizes twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors.

Open Access

Articles

Influence of Cassia mimosoides L. (Fabaceae) Density on Millet Yield [Pennisetum glaucum (L.) R. Br. (Poaceae)] in Eastern South East Niger

Mahamane Adamou, Adamou Ibrahim Maman Lawali, Abdourazak Alio Moussa, Toudou Daouda Abdoul‑Karim, Adamou Aboubacar Kolafane, Douma Soumana, Inoussa Maman Maarouhi, Mahamane Ali, Bakasso Yacoubou

Agricultural Sciences Vol.15 No.12, December 30, 2024

DOI: 10.4236/as.2024.1512086
Open Access

Articles

Phase I/II Study of Gefitinib and Concomitant Preoperative Radiotherapy in Patients with Locally Advanced Rectal Cancer

Abdelkarim S. Allal, Arnaud D. Roth, Alessandra Franzetti-Pellanda, Marta Bonet, Pascal Gervaz, Sabine Bieri

Journal of Cancer Therapy Vol.3 No.6A, November 30, 2012

DOI: 10.4236/jct.2012.326124
Open Access

Articles

Safety and Therapeutic Efficacy of the Lewis Y Carbohydrate Specific Humanized Antibody MB311 in Patients with Malignant Effusion

Thomas Bauernhofer, Helmut Samonigg, Peter Regitnik, Werner Weitzer, Brigitte Lileg, Günter Waxenecker, Susanne Wiederkum, Manuela Kainer, Manfred Schuster, Hans Loibner, Markus Fido, Ralf Kircheis, Andreas Nechansky

Journal of Cancer Therapy Vol.5 No.1, January 6, 2014

DOI: 10.4236/jct.2014.51004
Open Access

Articles

Specific Immunotherapy in Advanced Cervical-Uterine Cancer Using Humanized Monoclonal Antibody Nimotuzumab and CIMAvax-EGF^® Therapeutic Vaccine

Raiza Ruiz-Lorente, Sayly Alfonso, Eduardo Santiesteban, Yamilka Sánchez, Kirenia Camacho, Erasmo Mendoza, Carmen Elena Viada, Ramón Ortiz, Ihosvannys Carreño, Mayelin Troche, Meylan Cepeda, Ana Rosa Vals, Leticia Cabrera, Annia Gorte, Delmis Batista, Milagros Domenech, Yanela Santiesteban, Yuliannis Santiesteban, Daymys Estevez, Jessica García-Viamontes, Conrado Ramos Mico, Mayra Ramos-Suzarte

Journal of Cancer Therapy Vol.12 No.3, March 25, 2021

DOI: 10.4236/jct.2021.123016
Open Access

Articles

Reducing Effect of Parkia biglobosa (Jacq.) R. Br. ex G. Don Fruit Pulp on Food Intake in Healthy NMRI Mice

Emmanuel Zongo, Benjamin Kouliga Koama, Yaya Gnanou, Sami Eric Kam, Christian Ouedraogo, Mathieu Nitiema, Eliasse Zongo, Hadidjatou Belem, Dramane Paré, Windmi Kagambèga, Ollo Da, Georges Anicet Ouedraogo, Roland Nâg-Tiero Meda

Pharmacology & Pharmacy Vol.15 No.10, October 24, 2024

DOI: 10.4236/pp.2024.1510020

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals by Subject

Publish with us

Article citationsMore>>

Home

About SCIRP

Service

Policies